National trials for CCSVI treatment for MS patients to begin in November
Advertisement
Read this article for free:
or
Already have an account? Log in here »
We need your support!
Local journalism needs your support!
As we navigate through unprecedented times, our journalists are working harder than ever to bring you the latest local updates to keep you safe and informed.
Now, more than ever, we need your support.
Starting at $15.99 plus taxes every four weeks you can access your Brandon Sun online and full access to all content as it appears on our website.
Subscribe Nowor call circulation directly at (204) 727-0527.
Your pledge helps to ensure we provide the news that matters most to your community!
To continue reading, please subscribe:
Add Brandon Sun access to your Free Press subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $20.00 plus GST for four weeks. After four weeks, your payment will increase to $24.00 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 28/09/2012 (4839 days ago), so information in it may no longer be current.
A national clinical trial to test a controversial treatment for multiple sclerosis has received the necessary medical and ethical approvals to proceed, federal Health Minister Leona Aglukkaq announced today.
Recruitment for participants will begin Nov. 1 in Vancouver and Montreal. Participants will also be sought in Winnipeg and Quebec City, once ethics approval is granted for these centres to join. That could occur later in November.
Altogether, 100 MS patients will take part in the first phase of the clinical trials.
Dr. Anthony Traboulsee, medical director of the UBC Hospital MS Clinic, and his collaborators received ethics approvals from institutions in British Columbia and Québec to undertake the clinical trial for Chronic Cerebrospinal Venous Insufficiency (CCSVI) in persons with multiple sclerosis (MS).
CCSVI is a term used to describe the problem with blood flow in neck veins. Some doctors believe it plays a role in causing MS.